Low-renin hypertension affects 30% of patients with hypertension.
The most common cause of low-renin hypertension is primary aldosteronism, which presents with suppressed renin but elevated aldosterone concentrations.
Endocrinol Metab Clin N Am 48 (2019) 701–715
Low-renin hypertension with low aldosterone represents a wide spectrum of disorders, which includes hereditary monogenic forms, secondary to either endogenous or exogenous factors, and essential forms.
When evaluating a patient with low-renin hypertension, measurement of plasma aldosterone and potassium concentrations are followed by workup for differential diagnosis.
Traditionally, the evaluation of the renin profiling was based on plasma renin activity (PRA), a radioimmuno assay (RIA) that measures the quantity of angiotensin I generated as a function of time.
More recently, the direct renin concentration (DRC), measured by chemiluminescence, and the liquid chromatography with mass spectrometry for quantification of PRA have emerged as alternative methods.